Haemonetics Corp (HAE) reported earnings for its third quarter that increased from the same period last year and beat the Street estimates.
The company's bottom line totaled $37.494 million, or $0.74 per share. This compares with $31.241 million, or $0.61 per share, last year.
Excluding items, Haemonetics Corp reported adjusted earnings of $60.291 million or $1.19 per share for the period.
Analysts on average had expected the company to earn $1.17 per share. Analysts' estimates typically exclude special items.
The company's revenue for the period rose 3.7% to $348.542 million from $336.250 million last year.
Haemonetics Corp earnings at a glance (GAAP) :
-Earnings: $37.494 Mln. vs. $31.241 Mln. last year.-EPS: $0.74 vs. $0.61 last year.-Revenue: $348.542 Mln vs. $336.250 Mln last year.
HAE was down by 7.07 percent at $66.20 in the pre-market trade on the New York Stock Exchange.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.